Phase-out of CFC Consumption in the Manufacture of Aerosol Metered-dose Inhalers (MDIs) in the Russian Federation

Project Summary

The objectives of this project are (a) through appropriate technology transfer, to phase-out the consumption of 212 ODP tones of CFC-11 and CFC-12 (2010) used in the manufacture of Aerosol Metered-Dose Inhalers (MDIs) in the Russian Federation (RF) and (b) to reduce future GHG emissions by approx. 1.7 MMT CO2 t/equivalent, by introducing, through technology transfer a lower GHG propellant. The two MDI companies in the RF will require technology transfer from one, or more, established multinational enterprises that have experience in the development and manufacture of MDIs using CFC-free technologies, and who have the right to transfer such technology to the Russian Federation (RF) without infringement of any intellectual property related to either the drug molecule, the method of formulation, the design of the metering valve or actuator or the filling process. This proposal addresses the requirements for conversion of a manufacturing facility currently using CFCs to manufacture MDIs with CFC-free propellant.

Project Details

GEF Project ID
Project Type
Full-size Project
Project Approved
Russian Federation
Focal Areas
Funding Source
GEF Trust Fund
Implementing Agencies
United Nations Industrial Development Organization
Executing Agencies
Ministry of Natural Resources and Environment
GEF Period:
GEF - 5
Approval Fiscal Year:


Project Preparation Grant Amount
50,000 USD
GEF Project Grant
2,550,000 USD
Co-financing Total
5,600,000 USD
GEF Agency Fees
255,000 USD
Total Cost 8,200,000.00 USD

Project Timeline

Received by GEF
16 Sep 2010
Preparation Grant Approved
04 Feb 2011
Concept Approved
01 Nov 2010
Project Approved for Implementation
14 Nov 2011
Project closed
30 Apr 2015